Indication · Neurology & Neurosurgery
Brain aneurysm
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
264
Cleared or approved since 2000
PMA and De Novo
18
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
47
287 device trials in all
Devices
1 devices via De Novo. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Comaneci, Comaneci Petit, Comaneci 17
Rapid-Medical , Ltd. · De Novo · Temporary Coil Embolization Assist Device · newest 2019
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB DeviceActive, not recruiting
Microvention-Terumo, Inc.Public (4543.T)
NCT04839705 · 200 participants (planned) · Start Aug 24, 2022 · Primary completion May 8, 2027
Device: WEB · For: Wide Neck Bifurcation Intracranial Aneurysms
Sites: Hollywood, Florida; Orlando, Florida; Honolulu, Hawaii · 27 sites in all
286 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Device, Neurovascular Embolization (HCG)100
- Catheter, Percutaneous, Neurovasculature (QJP)84
- Guide, Wire, Catheter, Neurovasculature (MOF)36
- Clip, Aneurysm (HCH)17
- Intracranial Aneurysm Flow Diverter (OUT)8
- Applier, Aneurysm Clip (HCI)4
- Software For Visualization Of Vascular Anatomy And Intravascular Devices (PZO)4
- Intracranial Coil-Assist Stent (QCA)3
- Neurovascular Liquid Embolic Agent (SGU)3
- Agent, Injectable, Embolic (MFE)2
- Methyl Methacrylate For Aneurysmorrhaphy (JXH)1
- Intrasaccular Flow Disruption Device (OPR)1
- Temporary Coil Embolization Assist Device (PUU)1
Research
- Device studies on intracranial aneurysm across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.